North America Smart Inhalers Market
The North America Smart Inhalers Market size was valued at US$ 503.91 Mn in 2018 and is projected to reach US$ 3,749.90 Mn by 2027, growing at a CAGR of 25.7% during 2019 - 2027.
Report Coverage
- Product: Nebulizers and Inhalers
- Disorder: Chronic Obstructive Pulmonary Disease Asthma
- End User: Home-Care Settings and Hospitals & Clinics
US$ 503.91 Mn
Market size in 2018
US$ 3,749.90 Mn
Market Size by 2027
25.7%
CAGR, 2019 - 2027
2019-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Smart Inhalers Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Smart Inhalers Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Smart Inhalers Market Regional Analysis
6.2 North America Smart Inhalers Market Revenue 2016-2027 (US$ Million)
6.3 North America Smart Inhalers Market Forecast Analysis
7. North America Smart Inhalers Market Analysis – by Product
7.1 Nebulizers and Inhalers
- 7.1.1 Overview
- 7.1.2 Nebulizers and Inhalers: North America Smart Inhalers Market – Revenue and Forecast, 2016-2027 (US$ Million)
8. North America Smart Inhalers Market Analysis – by Disorder
8.1 Chronic Obstructive Pulmonary Disease Asthma
- 8.1.1 Overview
- 8.1.2 Chronic Obstructive Pulmonary Disease Asthma: North America Smart Inhalers Market – Revenue and Forecast, 2016-2027 (US$ Million)
9. North America Smart Inhalers Market Analysis – by End User
9.1 Home-Care Settings and Hospitals & Clinics
- 9.1.1 Overview
- 9.1.2 Home-Care Settings and Hospitals & Clinics: North America Smart Inhalers Market – Revenue and Forecast, 2016-2027 (US$ Million)
10. North America Smart Inhalers Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Smart Inhalers Market Breakdown, by Key Country, 2019 and 2027 (%)
- 10.2.1.1 North America Smart Inhalers Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Smart Inhalers Market Breakdown, by Product
- 10.2.1.1.2 US: North America Smart Inhalers Market Breakdown, by Disorder
- 10.2.1.1.3 US: North America Smart Inhalers Market Breakdown, by End User
- 10.2.1.2 Canada: North America Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Smart Inhalers Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Smart Inhalers Market Breakdown, by Disorder
- 10.2.1.2.3 Canada: North America Smart Inhalers Market Breakdown, by End User
- 10.2.1.3 Mexico : North America Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Smart Inhalers Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Smart Inhalers Market Breakdown, by Disorder
- 10.2.1.3.3 Mexico : North America Smart Inhalers Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 GlaxoSmithKline plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Adherium Ltd.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Vectura Group plc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Novartis AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Findair Sp. z o. o.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Cohero Health
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Crux Product Design Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Teva Pharmaceuticals
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 3M
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Amiko Digital Health Limited
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
